MENU
CABA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cabaletta Bio (CABA) Earnings Date & Reports

A.I. Advisor
published Earnings

CABA is expected to report earnings to rise 6.46% to -59 cents per share on November 07

Cabaletta Bio CABA Stock Earnings Reports
Q3'24
Est.
$-0.60
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.07
Q3'23
Beat
by $0.03
The last earnings report on August 08 showed earnings per share of -56 cents, missing the estimate of -54 cents. With 352.23K shares outstanding, the current market capitalization sits at 219.33M.
View a ticker or compare two or three
CABA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2929 Arch Street
Phone
+1 267 759-3100
Employees
103
Web
https://www.cabalettabio.com